Paper32473006
Hirudin Reduces the Expression of Markers of the Extracellular Matrix in Renal Tubular Epithelial Cells in a Rat Model of Diabetic Kidney Disease Through the Hypoxia-Inducible Factor-1α (HIF-1α)/Vascular Endothelial Growth Factor (VEGF) Signaling Pathway.
Pang X and 5 others. Med Sci Monit, 2020. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Hirudin Reduces the Expression of Markers of the Extracellular Matrix in Renal Tubular Epithelial Cells in a Rat Model of Diabetic Kidney Disease Through the Hypoxia-Inducible Factor-1α (HIF-1α)/Vascular Endothelial Growth Factor (VEGF) Signaling Pathway. Papers, record 32473006. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32473006
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Hirudin Reduces the Expression of Markers of the Extracellular Matrix in Renal Tubular Epithelial Cells in a Rat Model of Diabetic Kidney Disease Through the Hypoxia-Inducible Factor-1α (HIF-1α)/Vascular Endothelial Growth Factor (VEGF) Signaling Pathway.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetic Nephropathies | Major topic |
| Hirudins | Major topic |
| Kidney Tubules | Major topic |
| Animals | |
| Biomarkers | |
| Cells, Cultured | |
| China | |
| Disease Models, Animal | |
| Epithelial Cells | |
| Extracellular Matrix | |
| Hypoxia | |
| Hypoxia-Inducible Factor 1, alpha Subunit | |
| Male | |
| RNA, Messenger | |
| Rats | |
| Rats, Sprague-Dawley | |
| Real-Time Polymerase Chain Reaction | |
| Signal Transduction | |
| Vascular Endothelial Growth Factor A | |
| Vascular Endothelial Growth Factors |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30579729 | New pharmacological strategies for protecting kidney function in type 2 diabetes. | Lancet Diabetes Endocrinol | 2019 | https://conductscience.org/library/papers/30579729 | PubMed |
| 2 | 28840540 | A more tubulocentric view of diabetic kidney disease. | J Nephrol | 2017 | https://conductscience.org/library/papers/28840540 | PubMed |
| 3 | 31004547 | Repressive role of stabilized hypoxia inducible factor 1α expression on transforming growth factor β-induced extracellular matrix production in lung cancer cells. | Cancer Sci | 2019 | https://conductscience.org/library/papers/31004547 | PubMed |
| 4 | 22957530 | Thrombin-triggered angiogenesis in rat brains following experimental intracerebral hemorrhage. | J Neurosurg | 2012 | https://conductscience.org/library/papers/22957530 | PubMed |
| 5 | 25467616 | Microalbuminuria: a parameter that has changed diabetes care. | Diabetes Res Clin Pract | 2015 | https://conductscience.org/library/papers/25467616 | PubMed |
| 6 | 29033543 | Effect of echinacoside on kidney fibrosis by inhibition of TGF-β1/Smads signaling pathway in the db/db mice model of diabetic nephropathy. | Drug Des Devel Ther | 2017 | https://conductscience.org/library/papers/29033543 | PubMed |
| 7 | 31572545 | Astragaloside IV inhibits excessive mesangial cell proliferation and renal fibrosis caused by diabetic nephropathy via modulation of the TGF-β1/Smad/miR-192 signaling pathway. | Exp Ther Med | 2019 | https://conductscience.org/library/papers/31572545 | PubMed |
| 8 | 20877304 | The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease. | Nat Rev Nephrol | 2010 | https://conductscience.org/library/papers/20877304 | PubMed |
| 9 | 30651179 | Challenging the conventional wisdom on diabetic nephropathy: Is microalbuminuria the earliest event? | J Diabetes Complications | 2019 | https://conductscience.org/library/papers/30651179 | PubMed |
| 10 | 28760771 | Diabetic nephropathy - is this an immune disorder? | Clin Sci (Lond) | 2017 | https://conductscience.org/library/papers/28760771 | PubMed |
| 11 | 30324679 | RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition. | J Physiol | 2019 | https://conductscience.org/library/papers/30324679 | PubMed |
| 12 | 25845297 | Management of diabetic nephropathy: Recent progress and future perspective. | Diabetes Metab Syndr | 2015 | https://conductscience.org/library/papers/25845297 | PubMed |
| 13 | 26770977 | Natural Hirudin Increases Rat Flap Viability by Anti-Inflammation via PARs/p38/NF-κB Pathway. | Biomed Res Int | 2015 | https://conductscience.org/library/papers/26770977 | PubMed |
| 14 | 27423661 | Hypoxia in tissue repair and fibrosis. | Cell Tissue Res | 2016 | https://conductscience.org/library/papers/27423661 | PubMed |
| 15 | 30194718 | Hirudin Protects Ang II-Induced Myocardial Fibroblasts Fibrosis by Inhibiting the Extracellular Signal-Regulated Kinase1/2 (ERK1/2) Pathway. | Med Sci Monit | 2018 | https://conductscience.org/library/papers/30194718 | PubMed |
| 16 | 26553517 | Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. | Nat Rev Nephrol | 2016 | https://conductscience.org/library/papers/26553517 | PubMed |
| 17 | 16408108 | Renal fibrosis: new insights into the pathogenesis and therapeutics. | Kidney Int | 2006 | https://conductscience.org/library/papers/16408108 | PubMed |
| 18 | 26119175 | Insights into the Mechanisms Involved in the Expression and Regulation of Extracellular Matrix Proteins in Diabetic Nephropathy. | Curr Med Chem | 2015 | https://conductscience.org/library/papers/26119175 | PubMed |
| 19 | 28699703 | A positive feedback loop promotes HIF-1α stability through miR-210-mediated suppression of RUNX3 in paraquat-induced EMT. | J Cell Mol Med | 2017 | https://conductscience.org/library/papers/28699703 | PubMed |
| 20 | 25216787 | Nitric oxide in the normal kidney and in patients with diabetic nephropathy. | J Nephrol | 2015 | https://conductscience.org/library/papers/25216787 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42657136 | Natural products modulate renal metabolic reprogramming in diabetic kidney disease. | J Transl Int Med | 2026 | https://conductscience.org/library/papers/42657136 | PubMed |
| 41821729 | Traditional Chinese medicine in the treatment of diabetic kidney disease: the mechanisms of signaling pathways regulations. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/41821729 | PubMed |
| 41346967 | Qi-Gui-Sheng-Jiang-San Decoction Regulating Hypoxia Response Through Non-Oxygen-Dependent Pathway Improves Diabetic Kidney Disease: Coupling Network Pharmacology With Experimental Verification. | J Diabetes Res | 2025 | https://conductscience.org/library/papers/41346967 | PubMed |
| 41105819 | Tubular Injury in Diabetic Kidney Disease: Early Diagnosis and Intervention Strategies. | Diabetes Metab Res Rev | 2025 | https://conductscience.org/library/papers/41105819 | PubMed |
| 40612503 | Syndecan-1-mediated loading of VEGF-A into small extracellular vesicles facilitates peritubular capillary repair during AKI-to-CKD transition. | iScience | 2025 | https://conductscience.org/library/papers/40612503 | PubMed |
| 39995420 | Research progress of hypoxia-inducible factor-1α and zinc in the mechanism of diabetic kidney disease. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/39995420 | PubMed |
| 39905044 | Untargeted metabolomic and proteomic analysis implicates SIRT2 as a novel therapeutic target for diabetic nephropathy. | Sci Rep | 2025 | https://conductscience.org/library/papers/39905044 | PubMed |
| 38474541 | Hirudin in the Treatment of Chronic Kidney Disease. | Molecules | 2024 | https://conductscience.org/library/papers/38474541 | PubMed |
| 38344666 | Research progress on the treatment of diabetic nephropathy with leech and its active ingredients. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/38344666 | PubMed |
| 37863950 | Expression of TNFR1, VEGFA, CD147 and MCT1 as early biomarkers of diabetes complications and the impact of aging on this profile. | Sci Rep | 2023 | https://conductscience.org/library/papers/37863950 | PubMed |
| 37361521 | Ferroptosis: a new strategy for Chinese herbal medicine treatment of diabetic nephropathy. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37361521 | PubMed |
| 37159453 | Extracellular matrix and vascular dynamics in the kidney of a murine model for Marfan syndrome. | PLoS One | 2023 | https://conductscience.org/library/papers/37159453 | PubMed |
| 36364144 | The Role of Hypoxia-Inducible Factor-1 Alpha in Renal Disease. | Molecules | 2022 | https://conductscience.org/library/papers/36364144 | PubMed |
| 36119923 | A Molecular Mechanism Study to Reveal Hirudin's Downregulation to PI3K/AKT Signaling Pathway through Decreasing PDGFRβ in Renal Fibrosis Treatment. | Biomed Res Int | 2022 | https://conductscience.org/library/papers/36119923 | PubMed |
| 35855831 | Mechanism of Cornus Officinalis in Treating Diabetic Kidney Disease Based on Network Pharmacology. | Evid Based Complement Alternat Med | 2022 | https://conductscience.org/library/papers/35855831 | PubMed |
| 35848975 | Exploring the mechanism of hirudin in the treatment of diabetic kidney disease using network pharmacology combined with molecular docking verification. | J Tradit Chin Med | 2022 | https://conductscience.org/library/papers/35848975 | PubMed |
| 35378831 | Potential Molecular Mechanism of Yishen Capsule in the Treatment of Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking. | Diabetes Metab Syndr Obes | 2022 | https://conductscience.org/library/papers/35378831 | PubMed |
| 34977018 | Recent Developments in Extracellular Matrix Remodeling for Fat Grafting. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34977018 | PubMed |
| 34539795 | Exploring the Potential Mechanism of Tang-Shen-Ning Decoction against Diabetic Nephropathy Based on the Combination of Network Pharmacology and Experimental Validation. | Evid Based Complement Alternat Med | 2021 | https://conductscience.org/library/papers/34539795 | PubMed |
| 34212273 | Hirudin ameliorates diabetic nephropathy by inhibiting Gsdmd-mediated pyroptosis. | Cell Biol Toxicol | 2023 | https://conductscience.org/library/papers/34212273 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FN1 | 2335 | PubTator's text mining | https://conductscience.org/library/genes/2335 | NCBI Gene |
| HIF1A | 3091 | PubTator's text mining | https://conductscience.org/library/genes/3091 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32473006
GET https://conductscience.org/api/papers/v1/32473006/references?page=2